logo
In This Issue
The Interface Between Depression and Dementia: Where Are We With This Important Frontier?
Late-Life Depression, Mild Cognitive Impairment, and Dementia: Possible Continuum?
Aging, Brain Disease, and Reserve: Implications for Delirium
Antidepressant Medication and Executive Dysfunction: A Deleterious Interaction in Late-Life Depression
Sertraline for the Treatment of Depression in Alzheimer Disease
Incidence of Depression and Anxiety in the Spouses of Patients With Dementia: A Naturalistic Cohort Study of Recorded Morbidity With a 6-Year Follow-Up
Improving Depression and Enhancing Resilience in Family Dementia Caregivers: A Pilot Randomized Placebo-Controlled Trial of Escitalopram
Public Stigma: The Community's Tolerance of Alzheimer Disease
Interleukin-1β Serum Levels is Increased in Antidepressant-Free Elderly Depressed Patients
Psychiatric Disorders and Cognitive Dysfunction Among Older, Postmenopausal Women: Results From the Women's Health Initiative Memory Study
2-(1-{6-[(2-[Fluorine-18]Fluoroethyl)(Methyl) Amino]-2-Naphthyl} Ethylidene)Malononitrile (FDDNP) Positron Emission Tomography Patterns in Nondemented Populations
Response to Letter From Shin and Lee, Entitled “2-(1-{6-[(2-[Fluorine-18]Fluoroethyl)(Methyl) Amino]-2-Naphthyl} Ethylidene)Malononitrile Positron Emission Tomography Patterns in Nondemented Populations”